ActiveGirls physical activity program for hormone health and diabetes-risk prevention in girls ages 8–12
Official title: ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence
Run by Massachusetts General Hospital · NCT07102797 · Data updated 2026-11-12
This study will test whether a 6-month ActiveGirls program with coaching and messages helps girls ages 8–12 improve hormone health and lower markers of diabetes risk compared with a lower-intensity, delayed program.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years and up |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Somerville, Massachusetts) |
| Status | Recruiting |
| Started | November 24, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07102797 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Girls ages 8–12 who are premenarchal and at increased risk for PCOS or insulin resistance (for example due to BMI ≥85th percentile, maternal PCOS/GDM, premature adrenarche, or being small for gestational age) and who have a caregiver able to participate are ideal candidates.
✕Probably not a fit
Girls who are post-menarche, have diagnosed type 1 or type 2 diabetes, other endocrine conditions that affect insulin or androgens, or who are taking medications such as metformin, GLP-1 receptor agonists, insulin, or GnRH agonists are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a pilot randomized trial enrolling premenarchal girls ages 8–12 who are at elevated risk for PCOS or insulin resistance. Participants are randomized to a full-intensity intervention with health coaching plus educational texts/emails or a delayed, lower-intensity text-only intervention, with caregiver involvement to support at-home activity. Both groups complete objective measures of body composition, insulin dynamics, reproductive hormones, fitness, and continuous activity monitoring, plus surveys at baseline, 6 months, and 12 months. Baseline and 12-month visits are in person at the MGH Translational and Clinical Research Centers and the 6-month assessment is remote.
Why it matters
Potential benefit: If successful, the program could help at-risk girls increase physical activity, improve hormone balance, and reduce early markers of diabetes risk.
How similar studies have gone: Some family-based lifestyle and physical activity programs have improved weight and metabolic markers in youth, but interventions specifically targeting peripubertal prevention of PCOS and insulin resistance are limited and this pilot is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Caregiver: Caregiver of child (ie mother, father, or other legal guardian), English-speaking, Access to a device where they are able to receive study e-mails or texts * Child: English-speaking, Female, ages 8-12 years old at time of enrollment, Pre-menarchal at time of baseline visit, at risk for Polycystic Ovary Syndrome (PCOS)/insulin resistance, as defined by (1) History of maternal PCOS/maternal GDM, (2) BMI \>/= 85th percentile, (3) History of premature adrenarche, or (4) Small (\<10th %ile) for gestational age Exclusion Criteria (Child): * Medications at time of enrollment: Metformin, GLP-1R Agonist, Insulin, GnRH agonist * Endocrine conditions that would impact either insulin sensitivity, androgen concentrations, or growth * Insulin dynamics: Type 1 diabetes, Type 2 diabetes, Congenital Hyperinsulinism * Androgen Conditions: Adrenal tumor, Congenital Adrenal Hyperplasia * Hyperthyroidism or uncontrolled hypothyroidism (TSH \>7.0 mIU/mL) * Growth Hormone Deficiency * Medical conditions that would impact PA participation: Type 1 diabetes; Cardiovascular, neurologic, and/or musculoskeletal conditions limiting ability to participate in physical activity. * Other medical comorbidities that would limit generalizability of findings, including: Severe congenital heart disease, Congenital anomalies, Cystic fibrosis, Cerebral palsy, Condition requiring use of nasogastric, gastric tube, or other alternative method of feeding, Undiagnosed conditions with significant impact on child's growth and development; Significant cardiac, hepatic, oncologic, inflammatory, or psychiatric disease.
Where it's running
-
Massachusetts General Hospital
Somerville, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Rachel Whooten, MD MPH
- Email: rwhooten@mgh.harvard.edu
- Phone: 6176434585
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Ovarian drilling via vNOTES laparoscopy for PCOS patients
This study tests whether drilling the ovaries using vNOTES laparoscopy can help women with PCOS who did not respond to first-line medicines.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Lean Beef as Part of a Healthy Meal Plan for Adolescent Girls with PCOS/PMOS
This pilot study tests a lean beef–based meal plan to see if it improves blood sugar control and diet quality in adolescent girls with PCOS/PMOS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.